| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.21M | 54.07M | 53.19M | 58.57M | 61.16M | 61.60M |
| Gross Profit | 24.15M | 24.15M | 22.83M | 24.05M | 25.75M | 24.48M |
| EBITDA | 5.02M | 5.24M | -1.21M | 2.69M | 5.34M | 6.94M |
| Net Income | 2.32M | 2.45M | -3.53M | 514.00K | 3.11M | 4.33M |
Balance Sheet | ||||||
| Total Assets | 39.67M | 38.14M | 36.14M | 45.54M | 47.85M | 33.55M |
| Cash, Cash Equivalents and Short-Term Investments | 3.35M | 3.66M | 3.14M | 1.65M | 840.00K | 6.56M |
| Total Debt | 2.94M | 3.25M | 3.92M | 7.28M | 8.22M | 3.96M |
| Total Liabilities | 14.72M | 13.91M | 14.09M | 20.06M | 22.17M | 13.46M |
| Stockholders Equity | 24.95M | 24.22M | 22.05M | 25.48M | 25.68M | 20.09M |
Cash Flow | ||||||
| Free Cash Flow | 2.43M | 2.23M | 5.42M | 4.67M | -508.00K | 4.17M |
| Operating Cash Flow | 2.94M | 2.91M | 6.03M | 5.81M | 1.22M | 5.41M |
| Investing Cash Flow | -802.00K | -662.00K | -608.00K | -2.64M | -8.09M | -1.07M |
| Financing Cash Flow | -1.02M | -1.73M | -3.95M | -2.35M | 1.16M | -1.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £157.54M | 15.51 | 21.32% | 5.97% | 6.38% | -10.55% | |
72 Outperform | £15.76M | 4.66 | 9.67% | 3.17% | 2.83% | ― | |
66 Neutral | £242.29M | 3.91 | 30.98% | 2.12% | -0.89% | 1.30% | |
65 Neutral | £77.97M | -8.91 | -0.12% | ― | ― | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | £329.72M | 14.34 | -2.16% | 4.82% | -2.67% | 89.86% | |
42 Neutral | £24.18M | -0.15 | 97.34% | ― | -31.02% | -4458.82% |